Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/IRCT20221013056161N1
IRCT20221013056161N1RecruitingUnknown

The effect of low-dose apixaban in the treatment of symptomatic cases of radial artery occlusion following radial artery angiography.

Esfahan University of Medical Sciences0 sites30 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Unknown
Status
Recruiting
Enrollment
30
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
no limit to no limit (—)
Sex
All

Inclusion Criteria

  • •People who have undergone radial artery angiography
  • •Symptoms related to radial artery occlusion (such as pain and palpable radial pulse)
  • •Confirmed by Doppler imaging

Exclusion Criteria

  • •Lack of patient satisfaction
  • •The need for a therapeutic dose of anticoagulants
  • •The use of other anticoagulants
  • •Severe symptoms of vascular occlusion that require rapid intervention to restore the arterial channel
  • •Contraindications for apixaban use include severe drug sensitivity
  • •Active clinical and pathological bleeding such as gastrointestinal and cerebral
  • •hemostasis disorder and advanced renal failure

Investigators

Similar Trials

Recruiting
Not Applicable
The efficacy and safety of low dose apixaban in patients with non-valvular atrial fibrellation in real world practive: a prospective, multicenter , non-interventional studyDiseases of the circulatory system
KCT0005916Keimyung University Dongsan Hospital1,673
Recruiting
Phase 3
Comparison of the preventive effects of Apixaban and Enoxaparin on the postoperative vascular thromboembolism
IRCT20230419057967N1Bagheiat-allah University of Medical Sciences160
Active, not recruiting
Phase 1
Pharmacokinetics of apixaban in patients with short bowel syndrome requiring long-term parenteral nutrition.short bowel syndrome
CTIS2024-512061-14-00Z Leuven84
Recruiting
Phase 4
Pharmacokinetics of apixaban in patients with short bowel syndrome requiring long-term parenteral nutrition.short bowel syndrome
2024-512061-14-00UZ Leuven84
Recruiting
Phase 2
Apixaban in heparin-induced thrombocytopenia
IRCT20200325046854N1Iran University of Medical Sciences30